TB-500 (Thymosin Beta-4) — 10mg

Description

Thymosin Beta-4 is an endogenous 43-amino acid peptide that regulates actin polymerization — the process by which cells build the structural filaments required for migration, division, and repair. TB-500 is the active fragment (Ac-SDKP) responsible for most of Thymosin Beta-4’s tissue-healing activity. It promotes angiogenesis through upregulation of VEGF and angiopoietin; mobilizes endogenous stem cells from bone marrow to sites of injury; and reduces fibrosis in healing tissue, which improves scar quality and functional recovery. In cardiac tissue specifically, TB-500 has shown remarkable regenerative effects in preclinical models of myocardial injury.

For women, TB-500’s muscle-recovery and anti-fibrotic properties are relevant in training contexts, post-surgical healing, and any chronic injury where scar tissue formation is limiting recovery. Its stem cell mobilization effect is systemic — meaning it supports healing across multiple tissue sites simultaneously, unlike locally administered repair compounds. Stacked with BPC-157 (which addresses the vascular and growth factor side of repair), TB-500 provides the cell migration and stem cell component, making the combination more effective than either alone.

Female-calibrated dosing: 2.5–5mg subcutaneously twice weekly (loading phase, 4–6 weeks); then 2.5mg 1–2x/week (maintenance). Women often respond at 2.5mg 2x/week. Can be used continuously for chronic conditions or cycled for acute injury repair.

Storage: Store lyophilized powder below -20°C. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 30 days.